Madison, Wisconsin
United States
19
2026-02-19
The entities that hold a legal rights for patent applications filed by inventor Thomson James:
James Thomson from Madison, US has applied for patents for these inventions. The list has both pending applications and granted patents:
DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS
#2 | 2024-10-10GENERATING ALLOGENIC ENDOTHELIAL CELL-SEEDED VASCULAR GRAFTS AND METHODS OF USE THEREOF
#3 | 2024-09-26REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION
#4 | 2024-05-16COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS
#5 | 2024-02-29RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS
#6 | 2023-04-13DERIVATION OF HEPATOCYTES AND HEMATOPOIETIC PROGENITORS FROM HUMAN EMBRYONIC STEM CELLS
#7 | 2022-01-13PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPORGRAMMING
#8 | 2019-10-31PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPROGRAMMING
#9 | 2016-08-04Mouse model for engraftment potential
#10 | 2016-02-04Method of deriving mature hepatocytes from human embryonic stem cells
#11 | 2014-11-27RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS
#12 | 2014-11-27REPROGRAMMING IMMORTALIZED B CELLS
#13 | 2013-08-22Method of deriving mature hepatocytes from human embryonic stem cells
#14 | 2013-08-22PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPROGRAMMING
#15 | 2012-12-20Identifying genetic variation in affected tissues
#16 | 2012-07-05MODIFIED IPS CELLS HAVING A MUTANT FORM OF A HUMAN IMMUNODEFICIENCY VIRUS (HIV) CELLULAR ENTRY GENE
#17 | 2012-03-08Reprogramming immortalized B-cells to induced pluripotent stem cells
#18 | 2010-07-22OCT4 and SOX2 with SV40 T antigen produce pluripotent stem cells from primate somatic cells
#19 | 2010-01-07Methods for the production of iPS cells using non-viral approach
402245 ⎘